PALI vs ZTS · P/E 15, rev $500.0K vs P/E 25, rev $2.47B
Palisade Bio Inc (PALI) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PALI revenue for 2026-06-30 was $500.0K. Net income was -$20.2M. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
PALI currently screens at market cap $316.3M and trailing P/E 15.2. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the PALI and ZTS stock pages for the full models.
Not investment advice.